Home > Healthcare > Biotechnology > Biopharma > cancer stem cells therapy market
Get a free sample of Cancer Stem Cells Therapy Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cancer Stem Cells Therapy Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The key players operating in this market have established themselves through, continuous research & development, and a strong market presence. Gamida Cells, AbbVie Inc, and Astellas Pharma Inc account significant market share. These prominent players thrive through a combination of strategic approaches, diverse product portfolio, research and development initiatives, market understanding, and regulatory compliance.
Market players operating in the cancer stem cells therapy is as mentioned below:
Global market for cancer stem cells therapy was worth USD 4.4 billion in revenue in 2022 and may record USD 12 billion by end of 2032 due to the increasing cases of cancer along with the growing private and public initiatives
North America industry size is expected to grow at 10% CAGR from 2023-2032 owing to presence of exceptionally advanced healthcare infrastructure, featuring state-of-the-art hospitals, research institutions, and biotechnology companies
The breast type cancer segment accounted for 24.4% of the market share in 2022 propelled by the increased funding and public awareness
Gamida Cells, AbbVie Inc, Astellas Pharma Inc, Novadip Biosciences, ReNeuron Group plc, Celyad, Adna GmBH, Thermo Fisher Scientific, Genentech Inc, and Merck KGaA are some of the major cancer stem cells therapy firms